AlphaMadera's AlphaVal page computes SpartanNash Company's fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag SPTN as undervalued, fairly valued, or overvalued.

What is SpartanNash Company's fair value?

Fair value for SPTN is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value SPTN?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from SPTN's most recent reported fundamentals.

SPTN - SpartanNash Company

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $27.50 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

AlphaVal Unavailable

AlphaVal: SPTN revenue per share ($282) is 10x the stock price ($26.90). Financials likely reported in a foreign currency.